Please login to the form below

Not currently logged in
Email:
Password:

Takeda UK

This page shows the latest Takeda UK news and features for those working in and with pharma, biotech and healthcare.

Communiqué: big wins for obesity and sugar tax campaigners

Communiqué: big wins for obesity and sugar tax campaigners

Meanwhile, Aurora Healthcare Communications’ Travel with IBD campaign for Japanese pharma group Takeda and charity Crohn’s &Colitis UK won an award in the Excellence in Healthcare Collaboration and Partnerships category. ... The initiative aimed for

Latest news

More from news
Approximately 0 fully matching, plus 36 partially matching documents found.

Latest Intelligence

  • Japanese pharma pulls no punches with post-Brexit UK Japanese pharma pulls no punches with post-Brexit UK

    Takeda - notes that all its members conduct R&D in the UK and over £60m was invested by them directly in the country last year. ... It also recently launched neuroscience company Cerevance in Cambridge, Massachusetts in partnership with Lightstone

  • Deal Watch October 2016 Deal Watch October 2016

    Branded products. $600m royalties. $230m US. 2.6. Respiratory 2015. Takeda. Daxas Non US. ... Asset Acquisition. Pet vaccines in US. 885. Crescendo (UK). Takeda (JP).

  • Case study: Treatment guidance Case study: Treatment guidance

    Client:Takeda UK. Agency:Liberation Communications. Campaign:A Practical Guide to using Mepact (mifamurtide). ... Takeda UK wanted to support HCPs by providing a simple Practical Guide that enabled them to administer mifamurtide confidently and

  • Interview: Trevor Smith, Takeda Interview: Trevor Smith, Takeda

    The significance of this lays in the evolving nature of Takeda's portfolio. ... Vice President, New Portfolio. Takeda Pharmaceuticals Europe. Managing Director, Takeda UK.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    Takeda UK &Ireland has appointed Peter Wheatley Price as market access director, succeeding Ross Selby who moves to head the firm's new US-based global pricing, market access and health ... positions. Adam Zaeske, managing director of Takeda UK, said:

  • Takeda appoints UK & Ireland digital lead Takeda appoints UK & Ireland digital lead

    Marc Weeks takes up the newly-established role. Takeda UK &Ireland has appointed Marc Weeks to the newly-created position of digital lead. ... With rich previous experience working on digital pharmaceutical projects, Marc will fill a knowledge gap at

  • Ashfield Healthcare expands its board of directors Ashfield Healthcare expands its board of directors

    Most recently, she served as head of operations for Ashfield's UK business. ... Frater currently serves as national sales manager for the Takeda UK account.

  • Takeda UK adds to its senior leadership team Takeda UK adds to its senior leadership team

    Simon Meadowcroft and Pauline Bromley join the firm . Takeda UK has added new names to its senior team with the appointment of a new medical director and human resources director. ... Adam Zaeske, managing director of Takeda UK, said: “We are working

  • Adam Zaeske appointed as new MD of Takeda UK Adam Zaeske appointed as new MD of Takeda UK

    Promoted after 11 years with the company. Takeda UK has appointed Adam Zaeske as its new managing director of Takeda UK and Ireland. . ... He said: “I am delighted to be joining the UK and Ireland team.

More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics